Table 4 Three-year estimates of time-to-event end points
End point | 3-Year estimate (%) | 95% Confidence interval |
|---|---|---|
Progression-free survival | 83.0 | (69.8, 98.8) |
Overall survival | 94.9 | (89.5, 100) |
Local recurrence-free survival | 96.6 | (92.1, 100) |
Distant metastasis-free survival | 89.8 | (82.4, 97.9) |